Cross-reactive antigen is required to prevent erosion of established T cell memory and tumor immunity: A heterologous bacterial model of attrition

Journal of Immunology

Volumn 169, Issue 3, 2002, Pages 1197-1206

  Smith, Dean K ^a   Dudani, Renu ^a   Pedras Vasconcelos, Joao A ^a   Chapdelaine, Yvan ^a   Van Faassen, Henk ^a   Sad, Subash ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CROSS REACTING ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL INFECTION; CELL FUNCTION; CLONAL ANERGY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; LISTERIA MONOCYTOGENES; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

EID: 0036681639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.3.1197     Document Type: Article

References (64)

1. + T cell effector mechanisms in resistance to infection
2. T cell memory
3. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
4. Paracrine cytokine adjuvants in cancer immunotherapy
5. Cytotoxic T-cell memory without antigen
6. Immunological memory and protective immunity: Understanding their relation
7. On the role of antigen in maintaining cytotoxic T-cell memory
8. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen
9. Class II-independent generation of CD4 memory T cells from effectors
10. Persistence of memory CD8 T cells in MHC class I-deficient mice
11. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections
12. Altrition of T cell memory: Selective lass of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses
13. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
14. + T-cell memory determined by clonal burst size
15. Early programming of T cell populations responding to bacterial infection
16. + T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells
17. Differing roles of inflammalion and antigen in T cell proliferation and memory generation
18. T cell responses to bacterial infection
19. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance
20. 2 microglobulin-deficient mice
21. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection
22. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes
23. Role of hemolysin for the intracellular growth of Listeria monocytogenes
24. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice
25. Immunopathology of BCG infection in genetically resistant and susceptible mouse strains
26. + T cell priming initially: Comparison between an acute venus a chronic intracellular bacterium expressing a model antigen
27. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular α antigen
28. New use of BCG for recombinant vaccines
29. + T cell independent
30. Preexisting inflammation due to Mycobacterium bovis BCG infection differentially modulates T-cell priming against a replicating or nonreplicating immunogen
31. Introduction pf soluble protein into the class 1 pathway of antigen processing and presentation
32. Specific assays for cytokine production by T cells
33. Identification of a monoclonal antibody specific for a murine T3 polypeptide
34. Antigen presentation to cytotoxic T lymphocytes in vivo
35. The influence of immunologically committed lymphoid cells on macrophage activity in vivo
36. + effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor
37. Reversal of in vitro T cell clonal anergy by IL-2 stimulation
38. T cell clonal anergy
39. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists
40. Immunotherapy of bladder cancer
41. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice
42. Protective immunity elicited by recombinant hacille Calmette-Guérin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate Lyme disease vaccine
43. Acquired immunity to heavy infection with Mycobacterium bovis bacillus Calmette-Guérin and its relationship to the development of nonspecific unresponsiveness in vitro
44. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses
45. Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice
46. Immune response to infection with Mycobacterium ulcerans
47. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β
48. In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice
49. Macrophage-T cell interaction in experimental mgcobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response
50. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guérin organisms, and sensitize mice to mycobacterial antigens in vivo
51. Activation of human dendritic cells following infection with Mycobacterium tuberculosis
52. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation induced cell death
53. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses
54. Apoptosis of Th1-like cells in experimental tuberculosis (TB)
55. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
56. + T cell homeostasis by perforin and interferon-γ
57. γ Interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii
58. γ Interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: A possible role in immune response control
59. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages
60. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: Relative stability of CD4 memory under conditions of CD8 memory T cell loss
61. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses
62. Complications of bacillus Calmette-Guérin immunotherapy
63. Dendritic cells as adjuvants for immune-mediated resistance to tumors
64. Bacillus Calmette-Guérin-infected mice are more susceptible to staphylococcal enterotoxin B-mediated toxic shock in vivo despite reduced splenocyte responses to the superantigen in vitro